[{"id":"relugolix","kind":"drug","name":"Relugolix","route":"/drugs/relugolix/","commit":"ad64caf371","date":"2026-09-10","author":"Jude Gomila","message":"Primary source links (FDA label via DailyMed) for a fifth batch of approved products","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"links","after":"[{ label: \"FDA label (DailyMed)\", url: \"https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Relugolix\" }]"}]},{"id":"relugolix","kind":"drug","name":"Relugolix","route":"/drugs/relugolix/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/spikes/prostate.ts","type":"changed","fields":[{"field":"tldr","before":"\"The first hormone-suppressing pill for prostate cancer, working within days and wearing off quickly when stopped.\"","after":"\"Relugolix is the first hormone-suppressing pill for prostate cancer, working within days and wearing off quickly when stopped.\""}]}]